Reimagine your CDMO partnership

Find your missing element with Thermo Fisher Scientific


Thank you to everyone who connected with us at CPHI Barcelona. We enjoyed meeting you and exploring how we can support your drug development and manufacturing journey. If you missed us at the show, we’d still love to connect to discuss our industry-leading capabilities and unwavering commitment to building successful partnerships. 

Trend report: The nexus between patient and big pharma


Collaborations between CROs and CDMOs are on the rise, empowering the newly formed entities to provide even more capabilities to their biopharma partners. But what was initially considered to be a transient industry trend is now proving itself to be a sweeping paradigm shift. So, what’s the ultimate impact on patients? Thermo Fisher Scientific’s new trend report in collaboration with CPHI explores how CRO/CDMO collaborations are moving the needle in a brighter, more patient-centric direction.


Find your missing element with Thermo Fisher Scientific

Insights and resources


Continuing education for the pharma industry 


Follow us on social for event updates